Friday 6-13-2014 Achillion Pharmaceuticals (ACHN)
Post# of 94
Posted On: 06/13/2014 11:50:28 PM
Friday 6-13-2014 Achillion Pharmaceuticals (ACHN) $ACHN opened at 6.74 hitting the high price of 6.75 and a day low of 6.26 with a total volume of 9,018,557. ACHN had a previous close of 6.83 and has been seeing an average volume of 9,909,085.
Overall Average: 80% Buy
Recent stock forum discussions about ACHN http://investorshangout.com/search?q=ACHN&...mp;yt0=Go!
Nasdaq stocks posting largest percentage decreases
AP - Fri Jun 13, 12:23PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.: (full story)
Today's Top Biotech Stocks to Watch: Achillion Pharmaceuticals, Nektar Therapeutics and Progenics Ph
George Budwell, The Motley Fool - Motley Fool - Fri Jun 13, 8:02AM CDT
Let's take a look at today's top stories in biotech and health care. Keep an eye out for Achillion Pharmaceuticals , Nektar Therapeutics and Progenics Pharmaceuticals . Achillion falling back down to Earth Shares of hepatitis C... (full story)
If Achillion Pharmaceuticals (NASDAQ: ACHN) Investors Are Hoping for a Buyout, This is Not an Investment Strategy; Analyst Report by BrokerBank Securities, Inc.
PR Newswire - Fri Jun 13, 6:00AM CDT
Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) is a biopharmaceutical company that is engaged in the discovery, development and commercialization of innovative treatments for infectious diseases. Within the anti-infective market, the company is primarily focused on developing commercially competitive, short duration combination therapies for the treatment of chronic hepatitis C virus (HCV) that are once-daily and ribavirin-free. (full story)
Most active Nasdaq-traded stocks
AP - Thu Jun 12, 5:29PM CDT
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading: (full story)
Achillion Pharmaceuticals (ACHN) in Focus: Stock Falls 6.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jun 12, 7:36AM CDT
Achillion Pharmaceuticals stock fell over 6% last trading session, reversing its recent uptrend (full story)
Technical Update, Leadership Appointments, and Clinical Trial Results - Analyst Notes on Achillion, Nektar, CytRx, Galena and Receptos
PR Newswire - Thu Jun 12, 4:20AM CDT
Today, Analysts Review released its analysts' notes regarding Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN), Nektar Therapeutics (NASDAQ: NKTR), CytRx Corporation (NASDAQ: CYTR), Galena Biopharma, Inc. (NASDAQ: GALE) and Receptos, Inc. (NASDAQ: RCPT). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/3633-100free. (full story)
Achillion Surges Two Days in a Row, HCV in Focus - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jun 11, 4:10PM CDT
Achillion Pharmaceuticals, Inc. (ACHN) announced that the FDA has removed the clinical hold on its hepatitis C virus (HCV) candidate, sovaprevir. (full story)
4 Big Stocks on Traders' Radars
at The Street - Wed Jun 11, 1:45PM CDT
Here's a look at how some of the most active stocks on the market today are trading technically. (full story)
3 Stocks to Get on Your Watchlist
Sean Williams, The Motley Fool - Motley Fool - Wed Jun 11, 1:16PM CDT
I follow quite a lot of companies, so the usefulness of a watchlist for me cannot be overstated. Without my watchlist, I'd be unable to keep up with my favorite sectors and see what's really moving the market. Even worse, I'd be lost when the time... (full story)
Why Achillion Pharmaceuticals Inc. Shares Soured
Sean Williams, The Motley Fool - Motley Fool - Wed Jun 11, 12:38PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Achillion Pharmaceuticals , a... (full story)
Achillion Pharmaceuticals (ACHN) Stock Falls After Two Days of Gains
at The Street - Wed Jun 11, 9:20AM CDT
Achillion Pharmaceuticals (ACHN) plunged Wednesday as shares sold off from the previous two days' gains. (full story)
Stock Market News for June 11, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Wed Jun 11, 9:06AM CDT
Benchmarks ended Tuesday’s trading session little changed after investors took a breather (full story)
Achillion to Present at Two Upcoming Investor Conferences
GlobeNewswire - Wed Jun 11, 5:05AM CDT
Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) announced today that members of the senior management team will present a corporate overview at two upcoming investor conferences: (full story)
FDA lifts hold, Achillion soars
at Investor's Business Daily - Tue Jun 10, 6:06PM CDT
Shares rocketed 83.3% to 7.79 after the FDA let Achillion Pharmaceuticals (ACHN) resume hepatitis C drug trials. The FDA halted a Sovaprevir study last July amid concern over dangerous liver-enzyme elevations. Achillion shares jumped nearly 48% Mon.... (full story)
Nasdaq stocks posting largest volume increases
AP - Tue Jun 10, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading: (full story)
Overall Average: 80% Buy
Recent stock forum discussions about ACHN http://investorshangout.com/search?q=ACHN&...mp;yt0=Go!
Nasdaq stocks posting largest percentage decreases
AP - Fri Jun 13, 12:23PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.: (full story)
Today's Top Biotech Stocks to Watch: Achillion Pharmaceuticals, Nektar Therapeutics and Progenics Ph
George Budwell, The Motley Fool - Motley Fool - Fri Jun 13, 8:02AM CDT
Let's take a look at today's top stories in biotech and health care. Keep an eye out for Achillion Pharmaceuticals , Nektar Therapeutics and Progenics Pharmaceuticals . Achillion falling back down to Earth Shares of hepatitis C... (full story)
If Achillion Pharmaceuticals (NASDAQ: ACHN) Investors Are Hoping for a Buyout, This is Not an Investment Strategy; Analyst Report by BrokerBank Securities, Inc.
PR Newswire - Fri Jun 13, 6:00AM CDT
Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) is a biopharmaceutical company that is engaged in the discovery, development and commercialization of innovative treatments for infectious diseases. Within the anti-infective market, the company is primarily focused on developing commercially competitive, short duration combination therapies for the treatment of chronic hepatitis C virus (HCV) that are once-daily and ribavirin-free. (full story)
Most active Nasdaq-traded stocks
AP - Thu Jun 12, 5:29PM CDT
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading: (full story)
Achillion Pharmaceuticals (ACHN) in Focus: Stock Falls 6.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jun 12, 7:36AM CDT
Achillion Pharmaceuticals stock fell over 6% last trading session, reversing its recent uptrend (full story)
Technical Update, Leadership Appointments, and Clinical Trial Results - Analyst Notes on Achillion, Nektar, CytRx, Galena and Receptos
PR Newswire - Thu Jun 12, 4:20AM CDT
Today, Analysts Review released its analysts' notes regarding Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN), Nektar Therapeutics (NASDAQ: NKTR), CytRx Corporation (NASDAQ: CYTR), Galena Biopharma, Inc. (NASDAQ: GALE) and Receptos, Inc. (NASDAQ: RCPT). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/3633-100free. (full story)
Achillion Surges Two Days in a Row, HCV in Focus - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jun 11, 4:10PM CDT
Achillion Pharmaceuticals, Inc. (ACHN) announced that the FDA has removed the clinical hold on its hepatitis C virus (HCV) candidate, sovaprevir. (full story)
4 Big Stocks on Traders' Radars
at The Street - Wed Jun 11, 1:45PM CDT
Here's a look at how some of the most active stocks on the market today are trading technically. (full story)
3 Stocks to Get on Your Watchlist
Sean Williams, The Motley Fool - Motley Fool - Wed Jun 11, 1:16PM CDT
I follow quite a lot of companies, so the usefulness of a watchlist for me cannot be overstated. Without my watchlist, I'd be unable to keep up with my favorite sectors and see what's really moving the market. Even worse, I'd be lost when the time... (full story)
Why Achillion Pharmaceuticals Inc. Shares Soured
Sean Williams, The Motley Fool - Motley Fool - Wed Jun 11, 12:38PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Achillion Pharmaceuticals , a... (full story)
Achillion Pharmaceuticals (ACHN) Stock Falls After Two Days of Gains
at The Street - Wed Jun 11, 9:20AM CDT
Achillion Pharmaceuticals (ACHN) plunged Wednesday as shares sold off from the previous two days' gains. (full story)
Stock Market News for June 11, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Wed Jun 11, 9:06AM CDT
Benchmarks ended Tuesday’s trading session little changed after investors took a breather (full story)
Achillion to Present at Two Upcoming Investor Conferences
GlobeNewswire - Wed Jun 11, 5:05AM CDT
Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) announced today that members of the senior management team will present a corporate overview at two upcoming investor conferences: (full story)
FDA lifts hold, Achillion soars
at Investor's Business Daily - Tue Jun 10, 6:06PM CDT
Shares rocketed 83.3% to 7.79 after the FDA let Achillion Pharmaceuticals (ACHN) resume hepatitis C drug trials. The FDA halted a Sovaprevir study last July amid concern over dangerous liver-enzyme elevations. Achillion shares jumped nearly 48% Mon.... (full story)
Nasdaq stocks posting largest volume increases
AP - Tue Jun 10, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading: (full story)
(0)
(0)Alexion Pharmaceuticals Inc. (ALXN) Stock Research Links
Scroll down for more posts ▼